Contrast Media pp 257-274 | Cite as

Appendix A: ESUR Guidelines on Contrast Media Version 8.1

  • Henrik  S. Thomsen
  • Judith A.  W. Webb
Part of the Medical Radiology book series (MEDRAD)

Version 8.1 differs from version 8.0 because section A.3.4 has been updated.

Academic Members of the Contrast Media Safety Committee of the European Society of Urogenital Radiology


A.1 Non-renal adverse reactions

A.1.1 Acute adverse reactions

A.1.1.1 Acute adverse reactions to iodine-based contrast media

A.1.1.2 Acute adverse reactions to gadolinium-based contrast media

A.1.1.3 Management of acute adverse reactions

A.1.2 Late adverse reactions

A.1.3 Very late adverse reactions

A.1.3.1 Thyrotoxicosis

A.1.3.2 Nephrogenic systemic fibrosis

A.2 Renal adverse reactions

A.2.1 Renal adverse reactions to iodine-based contrast media

A.2.1.1 Time of referral

A.2.1.2 Before the examination

A.2.1.3 Time of examination

A.2.1.4 After the examination

A.2.2 Renal adverse reactions to gadolinium-based contrast media

A.2.3 Patients taking metformin

A.2.3.1 Iodine-based contrast media

A.2.3.2 Gadolinium-based contrast media

A.2.4 Dialysis and contrast medium administration

A.3 Miscellaneous



Contrast Medium Nephrogenic Systemic Fibrosis Contrast Medium Extravasation Urogenital Radiology Acute Adverse Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of Diagnostic RadiologyCopenhagen University HospitalHerlevDenmark
  2. 2.Diagnostic Radiology DepartmentSt Bartholomew’s HospitalLondonUK

Personalised recommendations